Form 4: 89bio CEO's Stock Withholding for Taxes
Insider Transaction Report
89bio CEO Rohan Palekar reported a disposition of 55,836 shares of common stock to cover tax obligations related to restricted stock unit vesting.
Summary
- Rohan Palekar, Chief Executive Officer and Director of 89bio, Inc., reported a change in beneficial ownership of the company's common stock.
- On August 1, 2025, 55,836 shares of 89bio common stock were disposed of at a price of $9.16 per share.
- This disposition was a 'tax withholding' transaction (Transaction Code F), meaning the shares were withheld from the vesting of restricted stock units to cover estimated tax obligations.
- Following this reported transaction, Palekar beneficially owns 808,070 shares of 89bio common stock.
- The total beneficial ownership includes an aggregate of 1,666 shares acquired by Palekar under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2025.
Sentiment
Score: 7
Explanation: The primary transaction is a routine tax withholding, which is neutral. The inclusion of shares acquired via an Employee Stock Purchase Plan is a minor positive, indicating continued insider investment.
Positives
- Rohan Palekar acquired 1,666 shares through the 2019 Employee Stock Purchase Plan on June 30, 2025, indicating continued investment in the company.
Stakeholder Impact
- Shareholders: This is a routine insider transaction for tax purposes and is not indicative of a change in management's confidence or the company's fundamental outlook.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Acquisition of 1,666 shares via Employee Stock Purchase Plan. |
| 08/01/2025 | Disposition of 55,836 shares for tax withholding related to restricted stock unit vesting. |
| 08/05/2025 | Date Form 4 was filed with the SEC. |
Recommendation
holdThis Form 4 reports a non-discretionary disposition of shares for tax withholding purposes upon RSU vesting, which is a common and expected event for executives. It does not signal a change in management's confidence or the company's fundamentals. The inclusion of shares acquired via an Employee Stock Purchase Plan further supports a neutral to slightly positive view on insider commitment. Therefore, the filing itself does not warrant a change in investment recommendation.
Keywords
89bio, ETNB, Rohan Palekar, Form 4, insider transaction, stock ownership, CEO, director, restricted stock units, tax withholding, employee stock purchase plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.